Multicenter retrospective study for brain metastases from breast cancer: Impact of molecular subtype on clinical outcomes

Multicenter retrospective study for brain metastases from breast cancer: Impact of molecular subtype on clinical outcomes - Multicenter retrospective study for brain metastases from breast cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000027908

Enrollment

300

Registered

2017-08-01

Start date

2017-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

brain metastases

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Breast cancer patients with brain metastases treated by gamma knife surgery are included. Gamma knife surgery was completed until March 31, 2017. The genetic phenotype of breast cancer is mandatory.

Exclusion criteria

Exclusion criteria: patients with undetermined genetic phenotype

Design outcomes

Primary

Measure	Time frame
Loss of functional independence Neurological death	—

Secondary

Measure	Time frame
Overall survival, tumor control, tumor recurrence, radiation injury, distant recurrence	—

Countries

Japan

Contacts

Public ContactKyoko Aoyagi

Chiba Cerebral and Cardiovascular Center Department of Neurosurgery

kyo-tsuru@nifty.com0436-88-3111

Outcome results